[
  {
    "ts": null,
    "headline": "Quest Diagnostics Incorporated (DGX) Presents at Jefferies 2025 Healthcare Services Conference Transcript",
    "summary": "Quest Diagnostics Incorporated (NYSE:DGX) Jefferies 2025 Healthcare Services Conference September 29, 2025 4:35 PM EDTCompany ParticipantsSam Samad -...",
    "url": "https://finnhub.io/api/news?id=6f89d9bcdad7e3799dfa30ca5f3b1752704a64398120010fee5d6d7eef8b0adf",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759172864,
      "headline": "Quest Diagnostics Incorporated (DGX) Presents at Jefferies 2025 Healthcare Services Conference Transcript",
      "id": 136919264,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "DGX",
      "source": "SeekingAlpha",
      "summary": "Quest Diagnostics Incorporated (NYSE:DGX) Jefferies 2025 Healthcare Services Conference September 29, 2025 4:35 PM EDTCompany ParticipantsSam Samad -...",
      "url": "https://finnhub.io/api/news?id=6f89d9bcdad7e3799dfa30ca5f3b1752704a64398120010fee5d6d7eef8b0adf"
    }
  },
  {
    "ts": null,
    "headline": "Why Guardant Health (GH) Stock Is Trading Up Today",
    "summary": "Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.6% in the morning session after the U.S. Food and Drug Administration (FDA) approved its Guardant360® CDx blood test as a companion diagnostic for Eli Lilly's new advanced breast cancer treatment, Inluriyo™.",
    "url": "https://finnhub.io/api/news?id=f934a509b20a7d16ee0881e3c711f843bb219ddbf83c04fe98a7775728ada9a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759162542,
      "headline": "Why Guardant Health (GH) Stock Is Trading Up Today",
      "id": 136916225,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.6% in the morning session after the U.S. Food and Drug Administration (FDA) approved its Guardant360® CDx blood test as a companion diagnostic for Eli Lilly's new advanced breast cancer treatment, Inluriyo™.",
      "url": "https://finnhub.io/api/news?id=f934a509b20a7d16ee0881e3c711f843bb219ddbf83c04fe98a7775728ada9a7"
    }
  },
  {
    "ts": null,
    "headline": "Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks",
    "summary": "During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 110 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Up",
    "url": "https://finnhub.io/api/news?id=b01537d6c178300c2dec20150971892953e9dc65ab31887f5c61fd498c3da066",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759156798,
      "headline": "Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks",
      "id": 136981361,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 110 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Up",
      "url": "https://finnhub.io/api/news?id=b01537d6c178300c2dec20150971892953e9dc65ab31887f5c61fd498c3da066"
    }
  }
]